» Articles » PMID: 38750095

Cholesterol Accumulation Impairs HIF-1α-dependent Immunometabolic Reprogramming of LPS-stimulated Macrophages by Upregulating the NRF2 Pathway

Overview
Journal Sci Rep
Specialty Science
Date 2024 May 15
PMID 38750095
Authors
Affiliations
Soon will be listed here.
Abstract

Lipid accumulation in macrophages (Mφs) is a hallmark of atherosclerosis. Yet, how lipid loading modulates Mφ inflammatory responses remains unclear. We endeavored to gain mechanistic insights into how pre-loading with free cholesterol modulates Mφ metabolism upon LPS-induced TLR4 signaling. We found that activities of prolyl hydroxylases (PHDs) and factor inhibiting HIF (FIH) are higher in cholesterol loaded Mφs post-LPS stimulation, resulting in impaired HIF-1α stability, transactivation capacity and glycolysis. In RAW264.7 cells expressing mutated HIF-1α proteins resistant to PHDs and FIH activities, cholesterol loading failed to suppress HIF-1α function. Cholesterol accumulation induced oxidative stress that enhanced NRF2 protein stability and triggered a NRF2-mediated antioxidative response prior to and in conjunction with LPS stimulation. LPS stimulation increased NRF2 mRNA and protein expression, but it did not enhance NRF2 protein stability further. NRF2 deficiency in Mφs alleviated the inhibitory effects of cholesterol loading on HIF-1α function. Mutated KEAP1 proteins defective in redox sensing expressed in RAW264.7 cells partially reversed the effects of cholesterol loading on NRF2 activation. Collectively, we showed that cholesterol accumulation in Mφs induces oxidative stress and NRF2 stabilization, which when combined with LPS-induced NRF2 expression leads to enhanced NRF2-mediated transcription that ultimately impairs HIF-1α-dependent glycolytic and inflammatory responses.

Citing Articles

Intracellular accumulation of free cholesterol in macrophages triggers a PARP1 response to DNA damage and PARP1 impairs lipopolysaccharide-induced inflammatory response.

Ting K, Ibrahim H, Gulati N, Wang Y, Rocheleau J, Cybulsky M PLoS One. 2025; 20(3):e0318267.

PMID: 40043029 PMC: 11882048. DOI: 10.1371/journal.pone.0318267.


Measuring the rate of NADPH consumption by glutathione reductase in the cytosol and mitochondria.

Ting K, Floro E, Dow R, Jongstra-Bilen J, Cybulsky M, Rocheleau J PLoS One. 2024; 19(12):e0309886.

PMID: 39637235 PMC: 11620681. DOI: 10.1371/journal.pone.0309886.


Revisiting the role of hypoxia-inducible factors and nuclear factor erythroid 2-related factor 2 in regulating macrophage inflammation and metabolism.

Ting K Front Cell Infect Microbiol. 2024; 14:1403915.

PMID: 39119289 PMC: 11306205. DOI: 10.3389/fcimb.2024.1403915.

References
1.
Maxwell P, Wiesener M, Chang G, Clifford S, Vaux E, Cockman M . The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999; 399(6733):271-5. DOI: 10.1038/20459. View

2.
Mahon P, Hirota K, Semenza G . FIH-1: a novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001; 15(20):2675-86. PMC: 312814. DOI: 10.1101/gad.924501. View

3.
Mills E, Ryan D, Prag H, Dikovskaya D, Menon D, Zaslona Z . Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018; 556(7699):113-117. PMC: 6047741. DOI: 10.1038/nature25986. View

4.
Masoud G, Li W . HIF-1α pathway: role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 2015; 5(5):378-89. PMC: 4629436. DOI: 10.1016/j.apsb.2015.05.007. View

5.
Koivunen P, Hirsila M, Gunzler V, Kivirikko K, Myllyharju J . Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem. 2004; 279(11):9899-904. DOI: 10.1074/jbc.M312254200. View